The Office for Research Compliance and Integrity :: The Research Institute at Nationwide Children's Hospital

Report a Concern Anonymously

The Office for Research Compliance and Integrity

The Office for Research Compliance and Integrity (ORCI) provides The Research Institute and Nationwide Children's Hospital with confidence that all research is conducted according to the highest scientific and ethical standards.

Contact:
Jessica Evans, RQAP-GLP
Director, Research Compliance
(614) 722-2599
Jessica.Evans@NationwideChildrens.org


ORCI is committed to furthering the mission and strategic plan of The Research Institute at Nationwide Children's Hospital by providing the institute with confidence that all research is conducted in compliance with applicable laws, rules, regulations and promotion of the highest scientific and ethical standards.

Cooperating Committees

ORCI requires the efforts and interactions of the following groups and committees:

  • IRB (the Institutional Review Board) for research involving humans

  • IACUC (the Institutional Animal Care and Use Committee) for research involving animals

  • IBCSC (the Institutional Biological and Chemical Safety Committee) for research involving hazardous materials, select agents or recombinant DNA

  • Patents, Copyrights and Conflicts of Interest Committee

  • The Office of Clinical Research Administration and the Clinical Studies Center at Nationwide Children's Hospital

 

Compliance Training

ORCI facilitates training and educational opportunities for managing compliance of federal regulations for research purposes.  Classroom instruction and personalized presentations are available. 

Clinical Research: Putting the Pieces Together

  • Module I:  Ethics and Regulations

  • Module II:  Study Management

Contact Debbie Bean, director of Research Services, at (614) 355-3416.

eIRB Training: Navigating the eIRB System
Contact Linda Wilson, IRB regulatory specialist, at (614) 722-2708.

 

Research Compliance Program

The Research Compliance program relies on the collaboration and combined efforts of researchers, support staff, and many others. The goal is to provide the information, support, and systems of administration needed to meet the laws, rules, and policies governing research in the most efficient and effective way. The compliance program is designed to be proactive, transparent, and integrated to prevent problems before they happen without impairing research.

In November 2005, the Department of Health and Human Services Office of Inspector General (OIG) released draft compliance program guidance for recipients of research awards from agencies of the U.S. Public Health Service. The document lists eight elements “widely recognized as fundamental to an effective compliance program.”

The Children’s Hospital Research Compliance Program’s foundation is based on these elements, which apply to all Children’s Hospital research staff, administrators, students, and other persons involved in the design, administration, financial management, conduct, and reporting of research of sponsored program activities at or through Children’s Hospital, regardless of the source of funding or the location where the activity is conducted.  

ORCI utilizes educational programming, research process auditing and open communication to ensure compliance with applicable laws, rules regulations and promotion of the highest scientific and ethical standards.

  • Education

    Education is a key component of compliance.  ORCI works closely with Education staff to develop training material and opportunities, and establish education requirements and documentation systems.

  • Auditing

    A critical component of the ORCI effort is conducting internal audits.  The audits are usually of a routine nature, but may be classified as “directed” or "for cause."

    Audits may be “directed” as requested by the IRB or as preparation of investigators for external inspection from a sponsor or regulatory authority (by conducting an internal “pre-audit” and facilitating remedial action as necessary).  “For cause” audits may be conducted when a problem is suspected:


    Studies for routine audit are chosen by random selection, based on risk level:

    *Unmonitored/minimal external monitoring

    *High profile

    *High enrolling

    *Investigator initiated

  • Communication

    Open communication is vital for developing institutional compliance.  Staff is welcome to contact us to ask questions, express an opinion, report research concerns or to get acquainted with our processes.  We look forward to meeting and assisting you. We look forward to meeting and assisting you.


Compliance Links

Ethical Principles and Codes
• The Belmont Report: Ethical Principles and Guidelines for the
Protection of Human Subjects in Research
• The Nuremberg Code: Directives for Human Experimentation
• World Medical Association Declaration of Helsinki

Office for Human Research
Protections (OHRP)

• OHRP Home Page
• OHRP IRB Glossary of Terms
• OHRP IRB Guidebook
• Protection of Human Subjects: 45 CFR 46

National Institutes of Health (NIH)
• HIPAA Privacy Rule: Information for Researchers
• NIH Clinical Trials Database
• NIH Health Information
• NIH Home Page
• NIH Office of Biotechnology Activities

U.S. Department of Health and Human Services (DHHS)
• DHHS Home Page
• DHHS Office for Civil Rights - HIPAA

Other Useful Links

Federal Resources
• Code for Federal Regulations
• Consumer Product Safety Commission
• National Aeronautics and Space Administration
• National Science Foundation
• U.S. Dept. of Agriculture
 U.S. Dept. of Commerce 
 U.S. Dept. of Defense
• U.S. Dept. of Education
• U.S. Dept. of Energy
• U.S. Dept. of Housing and Urban Development
• U.S. Dept. of Justice
• U.S. Dept. of Labor
• U.S. Dept. of Transportation
• U.S. Dept. of Veterans Affairs
• U.S. Environmental Protection Agency

Food and Drug
Administration (FDA)
• FDA Home Page
• Center for Drug Evaluation and Research
• FDA Guidance for IRBs and Clinical Investigators
• Good Clinical Practice in FDA-Regulated Clinical Trials
• Institutional Review Boards
• Investigational Device Exemptions: 21 CFR 812
• Investigational New Drug Application: 21 CFR 312
• Protection of Human Subjects: 21 CFR 50

 

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000